Publications by authors named "Peter Hiestand"

15Publications

Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions.

J Neuroinflammation 2010 Dec 22;7:95. Epub 2010 Dec 22.

Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland.

View Article and Find Full Text PDF
December 2010

Ascomycete derivative to MS therapeutic: S1P receptor modulator FTY720.

Prog Drug Res 2008 ;66:361, 363-81

Novartis Pharma AG, Lichtstrasse 35, 4002 Basel, Switzerland.

View Article and Find Full Text PDF
May 2008

Pyrazoloheteroaryls: novel p38alpha MAP kinase inhibiting scaffolds with oral activity.

Bioorg Med Chem Lett 2006 Jan 24;16(2):262-6. Epub 2005 Oct 24.

Novartis Institutes for BioMedical Research, Global Discovery Chemistry, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
January 2006

Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis.

Bioorg Med Chem Lett 2005 Dec 28;15(23):5160-4. Epub 2005 Sep 28.

Novartis Institutes for BioMedical Research, Global Discovery Chemistry, Autoimmunity and Transplantation, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
December 2005

SAR of benzoylpyridines and benzophenones as p38alpha MAP kinase inhibitors with oral activity.

Bioorg Med Chem Lett 2004 Jul;14(13):3601-5

Novartis Institutes for BioMedical Research, Arthritis and Bone Metabolism, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2004

Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis.

Bioorg Med Chem Lett 2004 Jul;14(13):3595-9

Novartis Institutes for BioMedical Research, Arthritis & Bone Metabolism, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2004